LRP4 and myasthenia gravis: Around 5% of MG patients without AChR antibodies present antibodies against the muscle specific kinase (MuSK) (13, 14) and only 1-5% against the Low-density lipoprotein receptor-related protein 4 (Lrp4) (15–17).